This page summarizes published research on pulsed electromagnetic fields, or PEMF, in people with knee osteoarthritis and in one postoperative knee study. It reports what named studies found and does not state what any device will do for a person with knee pain or another knee condition. It is part of ElectroMeds’ PEMF education library of research summaries.
This page covers one part of a wider topic. For the overview, see PEMF and Arthritis: What the Research Shows.
What researchers have studied
The knee literature is centered on knee osteoarthritis, often abbreviated as knee OA, rather than on knee pain as one broad category. The studies below used patient-reported measures such as the Western Ontario and McMaster Universities Osteoarthritis Index, known as WOMAC, visual analog pain scales, or the Knee injury and Osteoarthritis Outcome Score, known as KOOS. These tools record symptoms or function from the participant’s perspective; they do not establish that a device changes the underlying cause of knee symptoms.
The body of research includes two meta-analyses, several sham- or placebo-controlled knee-OA trials, and one postoperative arthroscopy study. These settings are not interchangeable. The available studies largely record short-term symptom or function measures rather than structural outcomes. Study devices, field settings, comparison groups, outcome measures, and follow-up periods varied. Results from early-OA, age-defined, or postoperative groups cannot be assumed to apply to a different diagnosis, device format, or use pattern.
The studies
Vavken et al. 2009 meta-analysis of knee-OA trials
Vavken and colleagues conducted a systematic review and meta-analysis of blinded randomized trials that compared PEMF with placebo for knee OA. They pooled nine studies involving 483 participants. In the combined analysis, the authors found no statistically significant difference between groups for pain or stiffness. They reported statistically significant pooled differences for activities of daily living and overall clinical scores.
This is an important mixed finding because the same review did not find a clear pain difference while reporting differences in some other outcomes. The underlying trials were small and did not all use identical devices or outcome measures. A pooled result cannot identify what a particular current device would do for an individual.
Vavken P, Arrich F, Schuhfried O, Dorotka R. “Effectiveness of pulsed electromagnetic field therapy in the management of osteoarthritis of the knee: a meta-analysis of randomized controlled trials.” J Rehabil Med. 2009;41(6):406-411. PMID: 19479151. DOI: 10.2340/16501977-0374.
Zorzi et al. 2007 postoperative arthroscopy trial
Zorzi and colleagues ran a prospective, randomized, double-blind pilot study in people who underwent arthroscopic treatment of knee cartilage. Thirty-one participants completed the study. The active and control groups used devices with different magnetic-field settings after procedures that included chondroabrasion, perforations, or radiofrequency work. The researchers recorded KOOS results and use of nonsteroidal anti-inflammatory drugs.
At 90 days, the active group had higher KOOS values than the control group, and the authors reported a statistically significant group difference. The study also reported a lower percentage of participants using nonsteroidal anti-inflammatory drugs in the active group and a difference in the authors’ three-year telephone outcome. These results belong to people recovering after specific arthroscopic cartilage procedures, not to the broader population with knee OA or unexplained knee pain. The trial was a pilot with 31 completers, and the abstract does not establish whether its findings apply outside that postoperative setting.
Zorzi C, Dall’Oca C, Cadossi R, Setti S. “Effects of pulsed electromagnetic fields on patients’ recovery after arthroscopic surgery: prospective, randomized and double-blind study.” Knee Surg Sports Traumatol Arthrosc. 2007;15(7):830-834. PMID: 17333120. DOI: 10.1007/s00167-007-0298-8.
Thamsborg et al. 2005 randomized, double-blind trial
Thamsborg and colleagues conducted a randomized, double-blind, placebo-controlled trial in 83 people with knee OA. The study recorded WOMAC activities of daily living, pain, and stiffness at baseline, during the six-week study period, and again six weeks after the study period. Within the active group, the authors reported statistically significant improvements from baseline on these measures at the scheduled evaluations. The placebo group also showed some improvements from baseline.
The key between-group analysis did not show statistically significant improvement over time for the full study population. In a subgroup of participants younger than 65 years, the authors reported a between-group difference for stiffness at two weeks, but not for activities of daily living or pain. This is a null overall result with a limited subgroup signal, not a consistent result across outcomes. The short study period, the subgroup analysis, and the absence of a full-population between-group difference limit what can be inferred about other people, devices, or longer timeframes.
Thamsborg G, Florescu A, Oturai P, Fallentin E, Tritsaris K, Dissing S. “Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study.” Osteoarthritis Cartilage. 2005;13(7):575-581. PMID: 15979009. DOI: 10.1016/j.joca.2005.02.012.
Ozgüçlü et al. 2010 trial alongside physical therapy
Ozgüçlü and colleagues randomly assigned 40 people with knee OA to PEMF or sham PEMF in addition to a physical-therapy program that included hot packs, therapeutic ultrasound, and terminal isometric exercises. The authors assessed WOMAC and visual analog scale outcomes at baseline and at the end of the two-week study period. Both groups showed statistically significant within-group improvement in WOMAC pain and function scores.
The authors found no statistically significant between-group differences in WOMAC pain, stiffness, physical function, or acetaminophen use after the study period. In other words, this trial did not find an additional difference for the PEMF group when both groups received the same physical-therapy program. The small sample, two-week follow-up, and co-interventions limit what can be separated. Its result also cannot answer a question about PEMF used without that program.
Ozgüçlü E, Cetin A, Cetin M, Calp E. “Additional effect of pulsed electromagnetic field therapy on knee osteoarthritis treatment: a randomized, placebo-controlled study.” Clin Rheumatol. 2010;29(8):927-931. PMID: 20473540. DOI: 10.1007/s10067-010-1453-z.
Nelson et al. 2013 early knee-OA pilot trial
Nelson and colleagues conducted a randomized, placebo-controlled, double-blind pilot study in 34 people with early knee OA. Participants had specified baseline pain and activity criteria, so the enrolled group was not a general knee-pain population. The study used visual analog scale pain scores as its main reported outcome over 42 days.
The active cohort’s mean pain score decreased by 50% plus or minus 11% from baseline, according to the abstract. The sham cohort did not show a statistically significant decrease from baseline, and the authors reported a statistically significant difference between the cohorts. The study did not establish persistence or applicability to function, structural change, other OA stages, or other diagnoses. It was explicitly a pilot study with 34 participants, so replication in larger, independently conducted trials would be needed to reduce uncertainty.
Nelson FR, Zvirbulis R, Pilla AA. “Non-invasive electromagnetic field therapy produces rapid and substantial pain reduction in early knee osteoarthritis: a randomized double-blind pilot study.” Rheumatol Int. 2013;33(8):2169-2173. PMID: 22451021. DOI: 10.1007/s00296-012-2366-8.
Viganò et al. 2020 systematic review and meta-analysis
Viganò and colleagues performed a systematic review and meta-analysis of randomized controlled trials of PEMF-based or magnetic-field interventions for knee OA. Their analysis included 13 studies and 914 unique participants. In the overall short-term analysis, the authors reported a statistically significant pooled reduction in self-reported pain scores. They did not find a statistically significant pooled improvement in activity scores.
The review also found that the comparison group and follow-up length influenced the results. When the authors pooled studies against alternative therapies, they reported no differences; longer follow-up correlated with smaller differences between groups. This synthesis is useful because it makes heterogeneity visible, but it combined interventions described as PEMF or magnetic fields and trials with different comparators. It describes a mixed, short-term evidence base rather than a single, uniform intervention or a result that can be generalized to every knee problem.
Viganò M, Perucca Orfei C, Ragni E, Colombini A, de Girolamo L. “Pain and Functional Scores in Patients Affected by Knee OA after Treatment with Pulsed Electromagnetic and Magnetic Fields: A Meta-Analysis.” Cartilage. 2022;13(1 Suppl):1749S-1760S. PMID: 32508140. DOI: 10.1177/1947603520931168.
How strong is this evidence?
The evidence is mixed and condition-specific. Several studies used randomized, blinded, or placebo-controlled designs, which are useful safeguards against expectations and natural symptom fluctuation. The reviews also bring together more participants than any individual trial. Yet the results do not point in one direction across all outcomes or comparisons. Vavken and colleagues found no significant pooled difference for pain or stiffness, while Viganò and colleagues found a short-term pooled pain difference but not a significant overall activity difference. Thamsborg and colleagues found no full-population between-group improvement, and Ozgüçlü and colleagues found no added between-group difference alongside a physical-therapy program.
The positive findings require the same caution. Nelson and colleagues reported a difference in a 34-person early-OA pilot. Zorzi and colleagues reported postoperative differences in 31 completers after particular arthroscopic cartilage procedures. These small, selected samples and specialized follow-up settings limit generalizability. Zorzi’s long-term contact is not broad replication in other postoperative populations.
Heterogeneity is a central limitation. Researchers used different electromagnetic-field settings, comparison conditions, schedules, symptom scales, and inclusion criteria. Some trials examined PEMF alongside other care, while others used a sham comparison. Follow-up was commonly short, and Viganò and colleagues observed smaller group differences with longer follow-up. The record supports careful description of individual findings, not a blanket conclusion about a device, a format, or knee pain in general.
What this means if you are considering a PEMF device
For a localized knee area, a portable applicator is the device format that most directly resembles the localized field placement studied in knee trials. That is a format comparison, not evidence that a device is appropriate for any person or that it will produce a particular outcome. A larger mat has a different physical format and does not automatically correspond to the knee-specific methods in these studies. ElectroMeds’ portable PEMF machine comparison explains the format distinction.
It is also important not to merge diagnoses under the label “knee pain.” Most of the evidence above concerns knee OA. The Zorzi trial concerns recovery after defined arthroscopic cartilage procedures. Neither body of evidence directly answers questions about a recent injury, ligament or meniscus problem, inflammatory arthritis, pain after joint replacement, or knee symptoms without a diagnosis. Product specifications, instructions, return terms, and the evidence for the exact use case are practical information to review separately.
Questions to ask before buying
- Does the seller identify the exact model and include a clear manual and technical specifications?
- Is the included applicator sized and shaped for placement over a localized knee area?
- What are the stated warranty, return-window, restocking-fee, and customer-support terms?
- Are the device’s controls, power source, cable length, and replacement-part availability clearly described?
- Does the seller provide the full research citation rather than a result without a traceable PMID or DOI?
- Where are the manufacturer’s listed contraindications and precautions presented before purchase?
This page summarizes published research for reference. It is not medical advice, and nothing here is a claim that any PEMF device treats, cures, or prevents any condition. PEMF is not appropriate for everyone — review PEMF contraindications and talk with your own physician before beginning any new therapy, particularly if you have an implanted electronic device, are pregnant, or are being treated for a serious medical condition.